Theravance Biopharma, Inc. revenue breakdown overview

Theravance Biopharma, Inc. revenue for the last year amounted to 57.42 M USD, the most of which — 57.42 M USD — came from its highest performing source at the moment, Human Therapeutics, the year earlier bringing 51.35 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Theravance Biopharma, Inc. 57.20 M USD, and the year before that — 51.12 M USD.